Audit 360242

FY End
2024-09-30
Total Expended
$67.55M
Findings
0
Programs
36
Organization: Hartford Healthcare Corporation (CT)
Year: 2024 Accepted: 2025-06-27

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.498 Covid-19 - Provider Relief Fund and American Rescue Plan (arp) Rural Distribution $43.12M Yes 0
97.036 Covid-19 - Disaster Grants - Public Assistance (presidentially Declared Disasters) $7.48M - 0
93.558 Temporary Assistance for Needy Families $1.61M - 0
93.958 Block Grants for Community Mental Health Sevices $1.54M - 0
93.242 Mental Health Research Grants $1.12M - 0
93.870 Maternal, Infant and Early Childhood Home Visiting Grant Program $851,363 - 0
93.914 Hiv Emergency Relief Project Grants $718,997 - 0
20.616 National Priority Safety Programs $697,847 - 0
93.732 Mental and Behavioral Health Education and Training Grants $588,076 - 0
93.268 Immunization Cooperative Agreements $528,608 - 0
93.959 Block Grants for Prevention and Treatment of Substance Abuse $481,234 - 0
93.155 Rural Health Research Centers $356,596 - 0
21.027 Covid-19 - Coronavirus State and Local Fiscal Recovery Funds $302,929 Yes 0
93.283 Centers for Disease Control and Prevention_investigations and Technical Assistance $296,305 - 0
84.425 Education Stabilization Fund $267,323 - 0
16.575 Crime Victim Assistance $265,409 - 0
93.273 Alcohol Research Programs $229,738 - 0
93.297 Teenage Pregnancy Prevention Program $179,938 - 0
93.994 Maternal and Child Health Services Block Grant to the States $125,287 - 0
93.800 Organized Approaches to Increase Colorectal Cancer Screening $120,932 - 0
93.276 Drug-Free Communities Support Program Grants $108,558 - 0
93.279 Drug Abuse and Addiction Research Programs $47,792 - 0
93.436 Well-Integrated Screening and Evaluation for Women Across the Nation (wisewoman) $43,315 - 0
14.267 Continuum of Care Program $39,973 - 0
93.855 Allergy and Infectious Diseases Research $34,358 - 0
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $29,501 - 0
12.420 Improving Outcomes in Lethal Prostate Cancer $29,321 - 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $22,540 - 0
93.669 Child Abuse and Neglect State Grants $20,417 - 0
93.924 Ryan White Hiv/aids Dental Reimbursement and Community Based Dental Partnership Grants $17,312 - 0
93.898 Cancer Prevention and Control Programs for State, Territorial and Tribal Organizations $15,000 - 0
14.228 Community Development Block Grants/state's Program and Non-Entitlement Grants in Hawaii $14,758 - 0
93.243 Substance Abuse and Mental Health Services_projects of Regional and National Significance $12,167 - 0
93.394 Cancer Detection and Diagnosis Research $9,444 - 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $7,993 - 0
93.837 Cardiovascular Diseases Research $7,244 - 0

Contacts

Name Title Type
SSEEF5MGC9H9 Carol Wardell Auditee
8606966283 Jessica Liconti Auditor
No contacts on file

Notes to SEFA

Title: 3. Noncash Assistance Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the Schedule) includes the federal grant activity of Hartford HealthCare Corporation and Subsidiaries’ (the Corporation) for the year ended September 30, 2024 and is presented on the accrual basis of accounting. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (the Uniform Guidance). For purposes of the Schedule, federal awards include any assistance provided by a federal agency directly or indirectly in the form of grants, contracts, cooperative agreements, loans and loan guarantees, or other non-cash assistance. In accordance with applicable requirements, certain grants are not dependent on expenditure activity and, accordingly, such grants are considered to be expended in the fiscal year of receipt; the grant program receipts of such awards are reflected in the expenditures column of the Schedule. Other programs may be presented in a certain fiscal year based on the program-specific guidance (see Notes 5 and 6). Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the Corporation’s consolidated financial statements. Direct and indirect costs are charged to awards in accordance with cost principles contained in the United States Department of Health and Human Services Cost Principles for Hospitals at 45 CFR Part 75 Appendix IX. Under these cost principles, certain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: Both Rate Explanation: The Uniform Guidance provides for a 10% de minimis indirect cost rate election. The Corporation uses a combination of a federally negotiated rate, award-specific rates, or the 10% de minimis rate by entity and program. During the year ended September 30, 2024, the U.S. Department of Health and Human Services issued $528,608 in Federal vaccines to the Corporation through the Immunization Cooperative Agreements program (Assistance Listing No. 93.268). These federal funds, which were passed through the State of Connecticut Department of Public Health, are included in the accompanying Schedule.
Title: 4. Consolidated Reporting Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the Schedule) includes the federal grant activity of Hartford HealthCare Corporation and Subsidiaries’ (the Corporation) for the year ended September 30, 2024 and is presented on the accrual basis of accounting. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (the Uniform Guidance). For purposes of the Schedule, federal awards include any assistance provided by a federal agency directly or indirectly in the form of grants, contracts, cooperative agreements, loans and loan guarantees, or other non-cash assistance. In accordance with applicable requirements, certain grants are not dependent on expenditure activity and, accordingly, such grants are considered to be expended in the fiscal year of receipt; the grant program receipts of such awards are reflected in the expenditures column of the Schedule. Other programs may be presented in a certain fiscal year based on the program-specific guidance (see Notes 5 and 6). Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the Corporation’s consolidated financial statements. Direct and indirect costs are charged to awards in accordance with cost principles contained in the United States Department of Health and Human Services Cost Principles for Hospitals at 45 CFR Part 75 Appendix IX. Under these cost principles, certain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: Both Rate Explanation: The Uniform Guidance provides for a 10% de minimis indirect cost rate election. The Corporation uses a combination of a federally negotiated rate, award-specific rates, or the 10% de minimis rate by entity and program. The federal award activity of the entities noted below is included in the accompanying Schedule for the year ended September 30, 2024: (See the Notes to the SEFA for table)
Title: 5. COVID-19 – Disaster Grants – Public Assistance (Presidentially Declared Disasters) Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the Schedule) includes the federal grant activity of Hartford HealthCare Corporation and Subsidiaries’ (the Corporation) for the year ended September 30, 2024 and is presented on the accrual basis of accounting. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (the Uniform Guidance). For purposes of the Schedule, federal awards include any assistance provided by a federal agency directly or indirectly in the form of grants, contracts, cooperative agreements, loans and loan guarantees, or other non-cash assistance. In accordance with applicable requirements, certain grants are not dependent on expenditure activity and, accordingly, such grants are considered to be expended in the fiscal year of receipt; the grant program receipts of such awards are reflected in the expenditures column of the Schedule. Other programs may be presented in a certain fiscal year based on the program-specific guidance (see Notes 5 and 6). Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the Corporation’s consolidated financial statements. Direct and indirect costs are charged to awards in accordance with cost principles contained in the United States Department of Health and Human Services Cost Principles for Hospitals at 45 CFR Part 75 Appendix IX. Under these cost principles, certain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: Both Rate Explanation: The Uniform Guidance provides for a 10% de minimis indirect cost rate election. The Corporation uses a combination of a federally negotiated rate, award-specific rates, or the 10% de minimis rate by entity and program. The Corporation incurred eligible disaster expenditures related to the COVID-19 pandemic. After a presidentially declared disaster, the Federal Emergency Management Agency (FEMA) provides Disaster Grants – Public Assistance (Presidentially Declared Disasters) (Assistance Listing No. 97.036) to reimburse eligible costs. In fiscal year 2024, FEMA approved $7,481,000 of eligible expenditures that were incurred in prior fiscal years. This amount has been included in the accompanying Schedule for the year ended September 30, 2024 in accordance with the guidance specific to Assistance Listing No. 97.036.
Title: 6. COVID-19 – Provider Relief Fund and American Rescue Plan (ARP) Rural Payments Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the Schedule) includes the federal grant activity of Hartford HealthCare Corporation and Subsidiaries’ (the Corporation) for the year ended September 30, 2024 and is presented on the accrual basis of accounting. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (the Uniform Guidance). For purposes of the Schedule, federal awards include any assistance provided by a federal agency directly or indirectly in the form of grants, contracts, cooperative agreements, loans and loan guarantees, or other non-cash assistance. In accordance with applicable requirements, certain grants are not dependent on expenditure activity and, accordingly, such grants are considered to be expended in the fiscal year of receipt; the grant program receipts of such awards are reflected in the expenditures column of the Schedule. Other programs may be presented in a certain fiscal year based on the program-specific guidance (see Notes 5 and 6). Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the Corporation’s consolidated financial statements. Direct and indirect costs are charged to awards in accordance with cost principles contained in the United States Department of Health and Human Services Cost Principles for Hospitals at 45 CFR Part 75 Appendix IX. Under these cost principles, certain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: Both Rate Explanation: The Uniform Guidance provides for a 10% de minimis indirect cost rate election. The Corporation uses a combination of a federally negotiated rate, award-specific rates, or the 10% de minimis rate by entity and program. In accordance with the requirements specific to Assistance Listing No. 93.498, COVID-19 – Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution, the amount presented on the accompanying Schedule for the year ended September 30, 2024 relates to Provider Relief Fund (PRF) payments received from January 1, 2023 through June 30, 2023 used for PRF-eligible activity from the period January 1, 2020 through June 30, 2023. This activity period and payment receipt period and the resulting amount presented reconciles to the PRF information previously reported to the Health Resources and Services Administration (HRSA) for PRF Reporting Period 7, as follows: (See the Notes to the SEFA for table) The lost revenues incurred by the Corporation during the period of availability for PRF Reporting Period 7 (January 1, 2020 through June 30, 2023) are in excess of the general and targeted distributions received in previous PRF Reporting Periods (which addressed payments received during April 10, 2020 to December 31, 2022, and previously reported on the applicable schedule of expenditures of federal awards for the years ended September 30, 2021, 2022 and 2023) and distributions received from July 1, 2021 through June 30, 2023 and, therefore, the amounts presented in the table above and on the accompanying Schedule are limited to the amount of such distributions.